You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • AB0664 Efficacy and Safety of Methylprednisolone Administered Intravenously for the Treatment of Patients with Active Ankylosing Spondylitis: Results of A 12-Week, Prospective, Open-Label Study (METALL)

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Spondyloarthritis - treatment
AB0664 Efficacy and Safety of Methylprednisolone Administered Intravenously for the Treatment of Patients with Active Ankylosing Spondylitis: Results of A 12-Week, Prospective, Open-Label Study (METALL)

 

Online download statistics by month:

Online download statistics by month: June 2014 to March 2024

AbstractFullPdf
Jun 2014200
Jul 2014300
Sep 2014900
Oct 2014300
Nov 2014400
Dec 2014701
Jan 2015200
Feb 2015100
Mar 2015302
Apr 2015300
May 2015200
Jun 2015100
Jul 2015400
Aug 2015400
Sep 2015600
Oct 2015200
Nov 2015400
Dec 2015200
Jan 2016900
Mar 2016400
Apr 2016200
May 2016200
Jun 2016500
Jul 2016700
Aug 2016300
Sep 2016300
Oct 2016600
Nov 20161402
Dec 2016800
Jan 20171400
Feb 2017900
Mar 20171200
Apr 20171400
May 20171501
Jun 20172002
Jul 2017600
Aug 20171400
Sep 20171800
Oct 2017400
Nov 2017801
Dec 20171201
Jan 20182000
Feb 2018800
Mar 20182600
Apr 2018600
May 20181200
Jun 2018200
Jul 20181000
Aug 20181001
Sep 2018800
Oct 2018401
Nov 2018800
Dec 2018600
Jan 2019200
Feb 2019201
Apr 2019600
May 2019200
Jun 2019200
Sep 2019200
Dec 2019201
Jul 2020200
Aug 2020400
Sep 2020800
Oct 2020601
Nov 2020200
Dec 2020901
Jan 2021200
May 2021200
Oct 2021200
Nov 2021200
Dec 2021800
Feb 2022400
Mar 2022400
Apr 2022200
May 2022200
Jun 2022200
Jul 20222000
Aug 20222200
Sep 20221200
Oct 2022400
Nov 2022200
Dec 2022600
Jan 2023200
Feb 20231000
Mar 2023200
Apr 2023400
May 2023400
Jul 2023600
Aug 2023400
Sep 2023200
Nov 2023400
Dec 20231800
Feb 2024200
Mar 20241000
Total604016